PHARMACEUTICALS: Getting Psych Meds May Be Tough For Part D Duals

Why This Topic Matters

The article is relevant to readers tracking Medicare drug benefit changes, Medicaid-to-Medicare transitions, and access issues for beneficiaries with mental illness or cognitive impairments. It highlights how coverage redesign can affect medication availability and continuity of care for vulnerable dual-eligible populations.

Article Sections

1. Medicare drug coverage transition for dual eligibles

   Introduces the Medicare Part D changeover and its potential impact on beneficiaries who currently receive drug coverage through Medicaid. It frames the issue around access to medications for low-income older adults and people with disabilities.

2. Reported concerns and policy priorities

   Summarizes the Medicare Rights Center report and the broad areas the authors say policymakers should address. The discussion focuses on access, continuity of care, and participation in low-income assistance.

3. Transition process and coverage concerns

   Describes worries about enrollment timing, systems changes, and beneficiary education during the move to the new benefit. It also discusses the risk of gaps in coverage during the transition.

4. Differences between Medicaid and Medicare drug coverage

   Compares general coverage approaches for psychiatric medications and explains why formulary and management practices may create access concerns under private Medicare plans and Medicare Advantage plans.